Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Kinase inhibitor for hearing loss protection

Dec. 7, 2020

Astellas conducts phase I/II study of ASP-0598 for chronic tympanic membrane perforation

July 28, 2020

Otonomy reports treatment response in phase I/II trial of OTO-313 for tinnitus

July 7, 2020

USP48 found to be involved in hereditary hearing loss in animal model

June 12, 2020

Sensorion reports preclinical findings on otoferlin gene therapy program

June 11, 2020

Base editing gives temporary hearing fix

June 11, 2020

FDA allows phase III protocol for SPI-1005 for Meniere's disease

June 10, 2020

Otoferlin gene therapy restores hearing in congenital deafness model

May 18, 2020

Autifony Therapeutics identifies new K(V)3 potassium channel modulators

April 30, 2020

Fetal pharmacotherapy in the developing inner ear may rescue congenital deafness

April 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...